Oncotarget

Selenium helps the body clock protect mice from chemotherapy toxicity by increasing the core clock protein BMAL1

Updated

Abstract

L-methyl-selenocysteine up-regulates BMAL1 expression in both cultured cells and mice.

  • Selenium compounds may reduce toxicity associated with anti-cancer treatments in certain models.
  • The circadian clock influences sensitivity to chemotherapy toxicity.
  • L-methyl-selenocysteine acts as a positive regulator of the core clock protein BMAL1.
  • Selenium's mechanism involves interference with TIEG1, which represses BMAL1 expression.
  • Selenium does not protect BMAL1-deficient mice from chemotherapy toxicity but does protect Clock mutant mice with normal BMAL1.
  • These findings suggest that selenium may enhance tissue protection through up-regulation of BMAL1.

Simplified

Full Text

We can’t show the full text here under this license.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free